MAIA Biotechnology, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

SUBSEQUENT EVENTS (Details Narrative)

SUBSEQUENT EVENTS (Details Narrative) - USD ($)										1 Months Ended	3 Months Ended						9 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Oct. 16, 2025	Oct. 08, 2025	Oct. 01, 2025	Jun. 03, 2025	May 08, 2025	Mar. 03, 2025	Feb. 24, 2025	Mar. 14, 2024	Aug. 01, 2022	Nov. 07, 2025	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2025	Nov. 25, 2025	Sep. 18, 2025	Jun. 17, 2025
Subsequent Event [Line Items]
Proceeds from sale of common stock											$ 117,136	$ 61,132	$ 130,220	$ 63,810	$ 315,314	$ 179,628
Private placement offerings												115,493	74,448		5,030	50,000
Warrants and rights exercisable period									Jan. 23, 2023
Issuance of shares, value											$ 3,662,115	$ 1,419,762	$ 1,390,871	$ 596,627	$ 6,801,664	$ 565,623
Exercise price warrants									$ 6.25										$ 1.30	$ 1.50
Common Stock [Member]
Subsequent Event [Line Items]
Issuance of shares											2,086,312	793,429	666,323	177,606	2,015,122	507,754
Issuance of shares, value											$ 209	$ 79	$ 67	$ 18	$ 202	$ 51
Private Placement [Member]
Subsequent Event [Line Items]
Common stock per share				$ 1.50	$ 1.50	$ 1.50	$ 1.50
Private placement offerings				$ 700,000	$ 1,080,000.00	$ 1,400,000	$ 2,700,000										$ 2,100,000
Warrants and rights exercisable period						Mar. 03, 2026	Feb. 24, 2031	Sep. 14, 2024
Exercise price warrants								$ 1.30
Private Placement [Member] \| Common Stock [Member]
Subsequent Event [Line Items]
Issuance of shares				463,332	719,999	952,633	1,810,000	2,496,318
Private Placement [Member] \| Investor Warrants [Member]
Subsequent Event [Line Items]
Issuance of shares				463,332	719,999	952,633	1,810,000
Common stock per share				$ 1.71	$ 2.05	$ 1.85	$ 1.87
H C Wainwright And Co LLC [Member] \| At The Market Offering Agreement [Member]
Subsequent Event [Line Items]
Issuance of shares											2,086,312			177,606
Common stock per share											$ 1.81			$ 3.72			$ 1.81
Proceeds from sale of common stock											$ 3,779,251			$ 660,437
Commissions paid											113,378			19,813
Other issuance cost														43,997
Net proceeds from common stock											$ 3,662,115			$ 596,627
Subsequent Event [Member]
Subsequent Event [Line Items]
Number of shares option										148,709
Weighted exercise price										$ 1.76
Subsequent Event [Member] \| Private Placement [Member]
Subsequent Event [Line Items]
Common stock per share	$ 1.22		$ 1.30
Private placement offerings			$ 2,300,000
Warrants and rights exercisable period	Oct. 16, 2028		Oct. 01, 2028
Proceeds from issuance of warrants	$ 700,000
Warrants to purchase of common stock																		11,475
Subsequent Event [Member] \| Private Placement [Member] \| Common Stock [Member]
Subsequent Event [Line Items]
Issuance of shares	603,769		1,733,766
Subsequent Event [Member] \| Private Placement [Member] \| Investor Warrants [Member]
Subsequent Event [Line Items]
Issuance of shares	603,769		1,733,766
Common stock per share	$ 1.52		$ 1.57
Subsequent Event [Member] \| Private Placement [Member] \| Investor Warrants [Member] \| Director [Member]
Subsequent Event [Line Items]
Private placement offerings			$ 25,000
Number of stock purchased			19,230
Issuance of warrants			19,230
Subsequent Event [Member] \| Issuance of Stock [Member]
Subsequent Event [Line Items]
Issuance of shares		7,348
Issuance of shares, value		$ 14,550
Share price		$ 1.98
Subsequent Event [Member] \| H C Wainwright And Co LLC [Member] \| At The Market Offering Agreement [Member]
Subsequent Event [Line Items]
Issuance of shares										236,271
Common stock per share										$ 1.78
Proceeds from sale of common stock										$ 420,780
Commissions paid										12,624
Other issuance cost										1,459
Net proceeds from common stock										$ 406,697